A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : uPA

Search Conditions:
Search Keyword : uPA
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: uPA
Appearance Frequency: 4149 time(s)
Long forms: 31

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
urokinase-type plasminogen activator
(3859 times)
Neoplasms
(929 times)
PAI-1 (621 times)
tPA (596 times)
uPAR (476 times)
1983 Glucocorticoids inhibit plasminogen activator production by endothelial cells.
urokinase-type PA
(218 times)
Cell Biology
(34 times)
PA (110 times)
tPA (106 times)
PAI-1 (57 times)
1985 Effect of dimethyl sulfoxide on human carcinoma cells, inhibition of plasminogen activator synthesis, change in cell morphology, and alteration of response to cholera toxin.
urokinase PA
(25 times)
Neurology
(4 times)
tPA (19 times)
PA (13 times)
PAs (9 times)
1989 Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
urokinase-type plasminogen
(12 times)
Neoplasms
(5 times)
BD-d (2 times)
ECM (2 times)
uPAR (2 times)
1993 Cytokine activation of human macro- and microvessel-derived endothelial cells.
urokinase-type activator
(6 times)
Medicine
(2 times)
PLG (3 times)
tPA (3 times)
ACA (1 time)
2003 Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
pro-urokinase
(2 times)
Vascular Diseases
(2 times)
FSAP (2 times)
FVII (2 times)
AF (1 time)
2008 Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
urinary PA
(2 times)
Urology
(1 time)
PA (1 time)
PAI-2 (1 time)
PAI1 (1 time)
1995 Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines.
urokinase Plg activator
(2 times)
Biochemistry
(1 time)
tPA (2 times)
actMMP-9 (1 time)
Ann-II (1 time)
2001 Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation.
Although plasminogen activator
(1 time)
Complementary Therapies
(1 time)
CRC (1 time)
EMT (1 time)
MMPs (1 time)
2019 Carnosine Suppresses Human Colorectal Cell Migration and Intravasation by Regulating EMT and MMP Expression.
10  anti-uPAR monoclonal antibody and proteolytically inactive urokinase
(1 time)
Allergy and Immunology
(1 time)
HUVECs (1 time)
uPAR (1 time)
2011 Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
11  endogenous plasminogen activator
(1 time)
Science
(1 time)
--- 1999 Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases.
12  particular plasminogen activator
(1 time)
Neoplasms
(1 time)
--- 1994 [Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer].
13  ubiquitous plasminogen by cell-derived urokinase-type
(1 time)
Pathology
(1 time)
uPAR (1 time)
1994 Plasminogen activation in healing human wounds.
14  uPA on cell surface urokinase
(1 time)
Biochemistry
(1 time)
uPAR (1 time)
1992 Occupancy of the cancer cell urokinase receptor (uPAR): effects of acid elution and exogenous uPA on cell surface urokinase (uPA).
15  uPA using AssayMax human urokinase
(1 time)
Biochemistry
(1 time)
EBV-EA (1 time)
TPA (1 time)
2012 Synthesis and docking studies of novel antitumor benzimidazoles.
16  uPAR and produce urokinase
(1 time)
Metabolism
(1 time)
ALP (1 time)
AP-1 (1 time)
KO (1 time)
2007 Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function.
17  uPAR binding to its proteolytic ligand, urokinase
(1 time)
Neoplasms
(1 time)
rt-TA (1 time)
uPAR (1 time)
2007 A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines.
18  uPAR but undetectable levels of urokinase
(1 time)
Cell Biology
(1 time)
CK18 (1 time)
uPAR (1 time)
1994 Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
19  uPAR in complex with both urokinase
(1 time)
Molecular Biology
(1 time)
uPAR (1 time)
2008 Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes.
20  uPAR mRNAs and a beta-globin reporter mRNA containing the ARE
(1 time)
Cell Biology
(1 time)
AREs (1 time)
MK2 (1 time)
2003 Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
21  uPAR purified from the ascitic fluid has no bound ligand
(1 time)
Medicine
(1 time)
--- 1993 A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.
22  uPAR, whether this interaction alone is critical to urokinase
(1 time)
Cell Biology
(1 time)
uPAR (1 time)
2008 Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.
23  upregulated, whereas Vimentin, N-cadherin, Plasminogen Activator, Urokinase
(1 time)
Biotechnology
(1 time)
AQP5 (1 time)
EMT (1 time)
MMP (1 time)
2018 Anti-cancer effect of Aquaporin 5 silencing in colorectal cancer cells in association with inhibition of Wnt/beta-catenin pathway.
24  upstream regions of the human urokinase
(1 time)
Hematology
(1 time)
JNK (1 time)
MAPK (1 time)
MP (1 time)
2004 MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription.
25  urinary plasminogen activator or urokinase
(1 time)
Neoplasms
(1 time)
ruPAR (1 time)
uPAR (1 time)
2002 Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
26  urinary-type
(1 time)
Dentistry
(1 time)
--- 2010 Urokinase and its receptor in follicular and inflammatory cysts of the jaws.
27  Urokinase Activation Plasminogen
(1 time)
Medicine
(1 time)
ER (1 time)
PgR (1 time)
2018 Correlation of Serum Levels of Urokinase Activation Plasminogen (uPA) and Its Inhibitor (PAI-1) with Hormonal and HER-2 Status in the Early Invasive Breast Cancer.
28  urokinase protein
(1 time)
Neoplasms
(1 time)
aFGF (1 time)
bFGF (1 time)
ELISA (1 time)
1998 Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha).
29  urokinase-type plasminogen activation system including urokinase
(1 time)
Pharmacy
(1 time)
GFD (1 time)
2019 Designing Tracers for PET Imaging of the Urokinase-type Plasminogen Activator Receptor from a Cyclic uPA-derived Peptide - First in Vitro Evaluations.
30  urotype PA
(1 time)
Dentistry
(1 time)
HGF (1 time)
PA (1 time)
PAI-1 (1 time)
1999 Enhancement of LPS-stimulated plasminogen activator production in aged gingival fibroblasts.
31  used as a therapeutic inhibitor of urokinase
(1 time)
Biochemistry
(1 time)
alpha 1-PI (1 time)
CT (1 time)
PAI-1 (1 time)
1990 Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils.